A REVIEW ON RECENT ADVANCES IN BRAIN TARGETED DRUG DELIVERY SYSTEM
Altaf Mulla*, Dr. Sameer Shafi, Bilal Saberi, Saqlain Mustaque
ABSTRACT
The blood- brain barrier (BBB) has been a great chain for brain medicine delivery. The BBB in healthy brain is a prolixity barrier essential for guarding normal brain function by impeding most composites from coursing from the blood to the brain; only small motes can cross the BBB. Under certain pathological conditions of conditions similar as stroke, diabetes, seizures, multiple sclerosis, Parkinson’s complaint and Alzheimer complaint, the BBB is disintegrated. The ideal of this review is to give a broad overview on current strategies for brain medicine delivery and related subjects from the once five times. It's hoped that this review could inspire compendiums to discover possible approaches to deliver medicines into the brain. After an original overview of the BBB structure and function in both healthy and pathological conditions, this review re-visits, according to recent publications, some questions that are controversial, similar as whether nanoparticles by themselves could cross the BBB and whether medicines are specifically transferred to the brain by laboriously targeted nanoparticles. Current non-nanoparticle strategies are also reviewed, similar as delivery of medicines through the passable BBB under pathological conditions and using non-invasive ways to enhance brain medicine uptake. Eventually, one particular area that's frequently neglected in brain medicine delivery is the influence of growing on the BBB, which is captured in this review grounded on the limited studies in the literature.
Keywords: Brain, Drug delivery, Blood-Brain barrier, Nano particles, etc.
[Full Text Article]
[Download Certificate]
Impact Factor : 8.181 
